← Back to guidelines
Cardiology6 papers

Cyclic oculomotor paralysis

Last edited: 4/23/2026

Overview

Cyclic oculomotor paralysis involves intermittent dysfunction of the oculomotor nerve, leading to symptoms such as ptosis, diplopia, and proptosis due to impaired muscle control and orbital dynamics 1.

Diagnosis

  • Key Diagnostic Criteria: Intermittent ptosis, diplopia, and passive ocular proptosis without evidence of external force or orbital pathology 1.
  • Recommended Tests:
  • - CT Imaging: Essential for excluding orbital disease and confirming the diagnosis by assessing orbital structures 1.
  • Grading: Not explicitly detailed in the provided abstracts.
  • Management

  • First-Line Treatments: Not specified in the provided abstracts.
  • Adjunctive Treatments: Not specified in the provided abstracts.
  • Special Populations

  • Pregnancy: Not addressed in the provided abstracts.
  • Pediatrics: Not addressed in the provided abstracts.
  • Elderly: Not addressed in the provided abstracts.
  • Comorbidities: Not addressed in the provided abstracts.
  • Key Recommendations

  • Utilize computerized tomography (CT) to evaluate patients presenting with passive ocular proptosis to rule out orbital disease and confirm the diagnosis of cyclic oculomotor paralysis 1 (Evidence: Moderate).
  • Consider the absence of external pathological forces and orbital disease as critical in diagnosing cyclic oculomotor paralysis 1 (Evidence: Moderate).
  • Further research is needed to establish definitive management guidelines for cyclic oculomotor paralysis [Expert opinion] (Evidence: Expert opinion).
  • References

    1 O'Neill BP. Passive ocular proptosis. Journal of neurology, neurosurgery, and psychiatry 1977. link

    Original source

    1. [1]
      Passive ocular proptosis.O'Neill BP Journal of neurology, neurosurgery, and psychiatry (1977)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG